Preventive CardiologyRelation of Black Race Between High Density Lipoprotein Cholesterol Content, High Density Lipoprotein Particles and Coronary Events (from the Dallas Heart Study)
Section snippets
Methods
The Dallas Heart Study (DHS) is a multiethnic, probability-based, population cohort study of Dallas County residents, with deliberate oversampling of black participants. The study design has been extensively described previously.3 Briefly, from 2000 to 2002, 2,971 participants completed a detailed in-home survey, laboratory testing, and imaging studies. For the present study, the study population comprised 1,977 participants who, at study entry, were not taking any lipid-lowering medications or
Results
The study comprised 1,977 adult participants; 51% were women, and 46% were black. Among men, blacks had highest median HDL-C and HDL-P and the largest median HDL particle size (Table 1). However, the magnitudes of the differences in median HDL-P (2%) and HDL particle size (3%) were smaller than those for HDL-C (17%). Among women, white women had the highest median HDL-C and HDL-P (Table 1). Unlike black men, black women had discordant HDL composition compared with white women (similar median
Discussion
In a large multiethnic, population-based cohort, we describe for the first time that factors that associate with levels of HDL-P, a novel marker of HDL composition, vary significantly from those that associate with HDL-C in an ethnicity- and gender-specific manner. This is also the first report to show that HDL-P is inversely associated with prevalent coronary calcium in the general population. In addition, we demonstrate that black ethnicity modifies the association between HDL-C and incident
Disclosures
Dr. McGuire has received consulting income from F. Hoffmann LaRoche, Genentech, Sanofi-Aventis, Daiichi Sankyo, Novo Nordisk, and Tethys Bioscience. Dr. Rohatgi has received grant support from Merck and is on the speaker’s bureau of AstraZeneca.
References (20)
- et al.
High-density lipoprotein cholesterol and particle concentrations, carotid atherosclerosis, and coronary events: MESA (Multi-Ethnic Study of Atherosclerosis)
J Am Coll Cardiol
(2012) - et al.
The Dallas Heart Study: a population-based probability sample for the multidisciplinary study of ethnic differences in cardiovascular health
Am J Cardiol
(2004) - et al.
African Americans and Caucasians have a similar prevalence of coronary calcium in the Dallas Heart Study
J Am Coll Cardiol
(2004) - et al.
Differential effects of fenofibrate and extended-release niacin on high-density lipoprotein particle size distribution and cholesterol efflux capacity in dyslipidemic patients
J Clin Lipidol
(2013) - et al.
High-density lipoprotein cholesterol, size, particle number, and residual vascular risk after potent statin therapy
Circulation
(2013) - et al.
Sex differences in the relationship between C-reactive protein and body fat
J Clin Endocrinol Metab
(2009) - et al.
Use and abuse of HOMA modeling
Diabetes Care
(2004) - et al.
Abdominal aortic atherosclerosis at MR imaging is associated with cardiovascular events: the Dallas Heart Study
Radiology
(2013) - et al.
High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies
Circulation
(1989) - et al.
2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines
Circulation
(2014)
Cited by (0)
The Dallas Heart Study was funded by the Donald W. Reynolds Foundation and was partially supported by the National Center for Advancing Translational Sciences of the National Institutes of Health, Bethesda, Maryland, under Award Number UL1TR001105. Dr. Rohatgi is supported by the National Heart, Lung, and Blood Institute of the National Institutes of Health under Award Number K08HL118131. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or the National Heart, Lung, and Blood Institute.
See page 894 for disclosure information.